Mizan-Tepi University Institutional Repository

Determinants of Disease Progression in Autosomal Dominant Polycystic Kidney Disease

Show simple item record

dc.contributor.author Asnake Kebede, Molla
dc.contributor.author Tadesse Mengistu, Yewondwosen
dc.contributor.author Yacob Loge, Biruk
dc.contributor.author Alemu Eshetu, Misikr
dc.contributor.author Pawlos Shash, Erkihun
dc.contributor.author Tolera Wirtu, Amenu
dc.date.accessioned 2025-01-28T11:11:44Z
dc.date.available 2025-01-28T11:11:44Z
dc.date.issued 2024-09-02
dc.identifier.citation https://www.mdpi.com/2075-4426/14/9/936 en_US
dc.identifier.uri http://repository.mtu.edu.et/xmlui/handle/123456789/227
dc.description.abstract Background: Despite its severity, there has been a lack of adequate study on autosomal dominant polycystic kidney disease (ADPKD) in Ethiopia. This study assessed the clinical profile and determinant factors contributing to renal disease progression. Methods: A retrospective study was conducted on 114 patients for 6 years in Addis Ababa. Patients with ADPKD who had follow-up visits at two health centers were included. Results: The mean age at diagnosis was 42.7 ± 12.7 years, with 43% reporting a positive family history of ADPKD. Approximately 22 patients (20%) developed endstage renal disease, and 12 patients died. The mean estimated glomerular filtration rate at the initial visit was 72.4 mL/min/1.73 m2 . The key risk factors associated with disease progression included younger age at diagnosis [adjusted Odds Ratio (aOR): 0.92, 95% CI: 0.87–0.98; p = 0.007], male gender (aOR: 4.5, 95% CI: 1.3–15.95, p = 0.017), higher baseline systolic blood pressure (aOR: 1.05, 95% CI: 1.01–1.10, p = 0.026), and the presence of comorbidities (aOR: 3.95, 95% CI: 1.10–14.33, p = 0.037). The progression of renal disease in ADPKD patients significantly correlates with age at diagnosis, gender, presence of comorbidities, and higher baseline systolic blood pressure. Conclusions: These findings underscore the importance of early detection and management of hypertension and comorbidities in ADPKD patients to mitigate disease progression and improve treatment outcomes. en_US
dc.description.sponsorship Mizan-Tepi University en_US
dc.language.iso en en_US
dc.subject autosomal dominant polycystic kidney disease; disease progression; clinical profile; Ethiopia en_US
dc.title Determinants of Disease Progression in Autosomal Dominant Polycystic Kidney Disease en_US
dc.type Other en_US


Files in this item

This item appears in the following Collection(s)

Show simple item record

Search MTU Repository


Advanced Search

Browse

My Account